Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
267.2 INR | +1.31% | -3.99% | +7.03% |
06:20pm | India's Biocon developing its own version of Wegovy, clinical trial likely next year | RE |
03:26am | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
- Stock Market
- Equities
- BIOCON Stock
- News Biocon Limited